SE intimation for Completin of Tenure of ID
Outcome of Board Meeting held on 2nd August 2023
Statement of deviation June 2023
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
SDD compliance certificate for the quarter ended 30th June 2023
Disclosure with respect to non-applicability of framework for Large Entities
Disclosure in terms of Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Statement of deviation or variation
Newspaper Publication for Website
Closure of trading window held on 28th June 2023
Outcome of Board Meeting held on 23rd May 2023
Publication of audited standalone and consolidated financial results in newspapers under Regulation 47 of SEBI Regulations, 2015.
Outcome of BM 8th August 2022
Outcome of Board Meeting 20th May 2022
Outcome of Board Meeting held on 18th April 2023
Intimation of Board Meeting to be held on 18th April 2023
Certificate under Regulation 74(5) of SEBI (Depositories and Partici pants) Regulations, 2018
Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015
Newspaper Publication dated 17.03.2023 Postal Ballot Notice
Outcome of Board Meeting 15.03.2023
Newspaper Publication UFR Dec 2022
Newspaper Publication Corrigendum to Notice of EOGM
Outcome of Board Meeting 07.02.2023
Newspaper Publication 25.01.2023
Outcome of BM 21.1.2023 Signed
Closure of Trading Window 30th December 2022
RPT Disclosures September 2022
Regulation 74(5) June 2022
Intimation to S.E of Board Meeting dt 05.09.2022
Cover Letter with Proceedings of AGM 01-08-2022
Intimation to SE of Board Meeting dt 05-09-2022 Signed
Reg 30 Calender of Event
Intimation of Board Meeting dated 20-05-2022
Public Notice Lyka Labs Limited 17-04-2021
Order Passed By SEBI in respect of GDR Issue
Closure of Register of Members and Share Transfer Books
Disclosure on Material Impact of COVID 19 on the Company
Resignation of Mrs. Neha A Thakore as an Independent Director
Confirmation regarding non applicability of Large Corporate Entity
SEBI order on GDR Issue
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter 31.03.2020
Closure of Trading Window
Appointment of Mr. Yogesh B Shah as an Executive Director
Outcome of Board Meeting held on 12.02.2020
Outcome of Board Meeting held on 13.01.2020
Clarification on Price Movement of Lyka Labs Limited
Disclosure of Related Party Transactions for the half year ended 30.09.2019
Appointment of Mr. Sandeep Parikh as an Additional Independent Director
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter 30.09.2019
Outcome of Board Meeting held on 09.08.2019
Appointment of Mr. Kunal N. Gandhi as Managing Director
Demise of Mr. Narendra I Gandhi
Disclosure of Related Party Transactions for the half year ended 31.03.2020
Outcome of Board Meeting held on 18.05.2019
Outcome of Board Meeting held on 01.11.2019
Merger update
Outcome of Board Meeting held on 18.05.2019
Disclosure of Large Corporate Entity
Closure of Trading Window
Insider Trading Update
Outcome of Board Meeting held on 12.02.2019
Appointment of Mr. Kunal N Gandhi as Joint Managing Director
Appoitment of Mr. Atit N. Shukla as an additonal Independent Director
Assignment of loan account of the Company by Kapol Bank to IARC Pvt Ltd
Completion of Tenure of Independent Directors
Compromise Settlement with Dena Bank
Appointment of Mr. Vinod S. Shanbhag as an Additonal Independent Director
Resigantion and Appointment of Company Secretary and Compliance Officer
Issue of Convertible Warrants to Promoter on Preferential Basis
Outcome of Board Meeting held on 30.08.2017
Dispensation of Issue of Warrants to Mr. Narendra I Gandhi
Publication of Unaudited Finanacial Results
Issue of Shares and Warrants to Promoters and Non Promoters on Preferential Basis
Merger of Lyka Healthcare Limited with Lyka Labs Limited
Out Licensing Deal with US Based Generics Company
Revision in Appointed date of Merger
Statment of Impact on Audit Qualification
Outcome of Board Meeting 09.11.2022
Closure of Trading Window June 2022
Closure of Trading Window September 2022
SE intimation 29/11/2022
Regulation 74(5) September 2022
Outcome of BM 05-09-2022
Intimation of Reconstitution of Various Committees
Reg 30 Re Appointment of Dhara P Shah as an Independednt Director for 2nd Term
Intimation to SE for Loan Payment_31st May, 2022
Letter of Open Offer by Ipca Laboratories Limited
Change in RTA
Outcome of Board Meeting
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30.06.2020
Disclosure of Related Party Transactions for the half year ended 31.03.2020
Closure of Trading Window
Outcome of Board Meeting held on 10.06.2020
Disclosure of Impact of COVID-19
Clarification on Price Movement of Lyka Labs Limited
Withdrawal of Preferential Issue of Shares and Warrants by Promoters
Appointment of Mr. Piyush G. Hindia as Company Secretary and Compliance Officer
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter 31.12.2019
Closure of Trading Window
Resignation of Mr. Abhishek D. Buddhadev as Company Secretary and Compliance Officer
Loan Agreement with International Asset Reconstruction Company Private Limited
Appointment of Mr. Abhishek D. Buddhadev as Company Secretary and Compliance Officer
Appointment of Statutory Auditor
Closure of Trading Window
Closure of Register of Members and Share Trasnfer Books
Closure of Trading Window
